Finance

Beta
Lists
PMOR:VIE
Philip Morris International Inc.
€152.10
+2.04%
(+3.04) 1D
Jun 3, 5:36:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PMOR...
Open
€149.38
High
€152.10
Low
€149.38
Mkt. cap
274.21B
Avg. vol.
6.00
Volume
0.00
52-wk high
€165.60
52-wk low
€124.64
No. of employees
85K
Open
€149.38
High
€152.10
Low
€149.38
Mkt. cap
274.21B
Avg. vol.
6.00
Volume
0.00
52-wk high
€165.60
52-wk low
€124.64
No. of employees
85K
News stories
From sources across the web
Profile
Philip Morris International Inc. is a tobacco company, with products sold in over 180 countries. Marlboro is PMI’s most recognized brand, but in the last quarter of 2023, Iqos generated the greatest revenue. Philip Morris International is often referred to as one of the companies comprising Big Tobacco. The company ranked No. 121 in the 2025 Fortune 500 list of the largest US corporations by total revenue. The company originated in 1847 in London, but Philip Morris International itself was established in 1987 as an operating company of Philip Morris Companies Inc. In 2003, Philip Morris Companies changed its name to Altria Group. In March 2008, PMI was spun off from Altria and has been an entirely separate entity since then. Philip Morris USA, a subsidiary of PMI's former parent, keeps ownership of the Philip Morris brands for the US market. The company's legal seat is in Stamford, Connecticut. PMI's operational headquarters are in Lausanne, Switzerland. With tobacco being addictive and a leading cause of preventable death globally, the company has faced litigation and regulatory measures from governments and has been the subject of scrutiny by the World Health Organization. Wikipedia
About Philip Morris International Inc.
CEOJacek Olczak
Employees84.9K
Founded1847
HeadquartersStamford, Connecticut, United States
SectorTobacco
Websitepmi.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
10.14B
10.84B
10.36B
10.15B
Cost of goods sold
3.28B
3.49B
3.56B
3.24B
Cost of revenue
3.28B
3.49B
3.56B
3.24B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.77B
2.94B
3.39B
3.24B
Operating expense
1.78B
2.94B
3.39B
3.25B
Total operating expenses
5.06B
6.43B
6.95B
6.49B
Operating income
5.08B
4.42B
3.41B
3.66B
Other non operating income
-
-
-
-
EBT including unusual items
3.80B
4.36B
2.92B
3.26B
EBT excluding unusual items
4.08B
4.52B
2.81B
3.28B
Income tax expense
652.00M
751.00M
675.00M
676.00M
Effective tax rate
17.16%
17.21%
23.08%
20.75%
Other operating expenses
9.00M
-
-
7.00M
Net income
3.04B
3.48B
2.14B
2.44B
Net profit margin
29.97%
32.07%
20.66%
24.03%
Earnings per share
1.91
2.24
1.70
1.96
Interest and investment income
-
-
621.00M
-
Interest expense
-437.00M
-403.00M
-343.00M
-391.00M
Net interest expenses
-437.00M
-403.00M
278.00M
-391.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
5.57B
4.92B
3.93B
4.17B
Gain or loss from assets sale
-
-
94.00M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more